Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Therapeutic Advances in Medical Oncology|March 17, 2025
Immunotherapy in advanced, KRAS G12C-mutant non-small-cell lung cancer: current strategies and future directionsNadia Ghazali, Marina C Garassino, Natasha B Leighl, et al.Therapeutic Advances in Medical Oncology|July 27, 2011
Targeted therapies in small cell lung cancer: a reviewAidalena Z Abidin, Marina C Garassino, Raffaele Califano, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2021
On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinomaColin R Lindsay, Marina C Garassino, Ernest Nadal, et al.Frontiers in Oncology|April 16, 2026
Immune checkpoint inhibitors in resectable non-small cell lung cancer: recent successes and ongoing challengesFaith O Abodunrin, Robert B Cameron, Waqas Haque, et al.Clinical Lung Cancer|April 9, 2020
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled AnalysisNalan A Babacan, Isabel B Pina, Diego Signorelli, et al.International Journal of Molecular Sciences|June 10, 2023
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung CancerJacobi B Hines, Benjamin Bowar, Emma Levine, et al.Journal of Experimental & Clinical Cancer Research : CR|December 6, 2018
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approachElisa Caiola, Francesca Falcetta, Silvia Giordano, et al.Anti-Cancer Drugs|November 21, 2012
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumorsMassimo Di Maio, Emilio Bria, Giuseppe L Banna, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 9, 2016
G48A, a New KRAS Mutation Found in Lung AdenocarcinomaMirko Marabese, Elisa Caiola, Marina C Garassino, et al.Scientific Reports|January 19, 2018
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenibElisa Caiola, Roberta Frapolli, Michele Tomanelli, et al.Pageof 8